AKT1 and diffuse large B-cell lymphoma: Therefore, these results suggested that CD300A knockdown was selectively toxic to PI3K inhibition-sensitive DLBCL cells, and PI3K/AKT pathway may play a role in mediating CD300A's effect on cell growth.